Study of SGN1 in Patients With Advanced Solid Tumor
Clinical trial NCT05038150 · RECRUITING
Trial details
- NCT number
- NCT05038150
- Sponsor
- Guangzhou Sinogen Pharmaceutical Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-16
- Primary completion
- 2028-01-18
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.